1 Min Read
May 24 (Reuters) - Zhejiang Hisun Pharmaceutical Co.,Ltd.:
* Receives clinical trial permission from State Food and Drug Administration, for fidaxomicin
Source text in Chinese: me2.do/G3blaw4c
Further company Coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.